Deyan Y. Yosifov, PhD

Division of CLL, Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany, Germany

Poster(s):

• 1108 - CLL10000: Robust Classification of 1172 ATM Variants employing a Five-Factor Score derived from matched Non-Tumor Controls

• 1425 - IGLV3-21R110 as a prognostic marker for early stage CLL patients – clinical implications in patients treated with BTK inhibitors and diagnostic challenges